RAC1 GTPase plays an important role in γ-irradiation induced G 2/M checkpoint activation

Breast Cancer Research

Volumn 14, Issue 2, 2012, Pages

  Yan, Ying ^a   Greer, Patrick M ^a   Cao, Phu T ^a   Kolb, Ryan H ^a   Cowan, Kenneth H ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATR PROTEIN; BOTULINUM TOXIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; RAC1 PROTEIN; SMALL INTERFERING RNA; 4 AMINO 6 [2 [[4 (DIETHYLAMINO) 1 METHYLBUTYL]AMINO] 6 METHYL 4 PYRIMIDINYL] 2 METHYLQUINOLINE; AMINOQUINOLINE DERIVATIVE; CDC2 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN B; DNA BINDING PROTEIN; ENZYME INHIBITOR; MAP2K1 PROTEIN, HUMAN; MAP2K2 PROTEIN, HUMAN; MAPK1 PROTEIN, HUMAN; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; PYRIMIDINE DERIVATIVE; RAC1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; TYROSINE;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IRRADIATION; PROTEIN EXPRESSION; RADIATION EXPOSURE; BREAST TUMOR; DRUG ANTAGONISM; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; GAMMA RADIATION; GENETICS; M PHASE CELL CYCLE CHECKPOINT; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AMINOQUINOLINES; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; CYCLIN B; DNA-BINDING PROTEINS; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; G2 PHASE CELL CYCLE CHECKPOINTS; GAMMA RAYS; HUMANS; M PHASE CELL CYCLE CHECKPOINTS; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PYRIMIDINES; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; TYROSINE;

EID: 84859513105     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3164     Document Type: Article

References (60)

1. Motoyama N, Naka K. DNA damage tumor suppressor genes and genomic instability. Curr Opin Genet Dev 2004, 14:11. 10.1016/j.gde.2003.12.003, 15108799.
2. Iliakis G, Wang Y, Guan J, Wang H. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 2003, 22:5834-5847. 10.1038/sj.onc.1206682, 12947390.
3. Smits VA, Medema RH. Checking out the G(2)/M transition. Biochim Biophys Acta 2001, 1519:1-12.
4. Rhind N, Furnari B, Russell P. Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast. Genes Dev 1997, 11:504-511. 10.1101/gad.11.4.504, 9042863.
5. Kharbanda S, Saleem A, Datta R, Yuan ZM, Weichselbaum R, Kufe D. Ionizing radiation induces rapid tyrosine phosphorylation of p34cdc2. Cancer Res 1994, 54:1412-1414.
6. O'Connell MJ, Raleigh JM, Verkade HM, Nurse P. Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. EMBO J 1997, 16:545-554. 10.1093/emboj/16.3.545, 1169658, 9034337.
7. Lundgren K, Walworth N, Booher R, Dembski M, Kirschner M, Beach D. mik1 and wee1 cooperate in the inhibitory tyrosine phosphorylation of cdc2. Cell 1991, 64:1111-1122. 10.1016/0092-8674(91)90266-2, 1706223.
8. Parker LL, Atherton-Fessler S, Piwnica-Worms H. p107wee1 is a dual-specificity kinase that phosphorylates p34cdc2 on tyrosine 15. Proc Natl Acad Sci USA 1992, 89:2917-2921. 10.1073/pnas.89.7.2917, 48774, 1372994.
9. Bulavin DV, Higashimoto Y, Demidenko ZN, Meek S, Graves P, Phillips C, Zhao H, Moody SA, Appella E, Piwnica-Worms H, Fornace AJ. Dual phosphorylation controls Cdc25 phosphatases and mitotic entry. Nat Cell Biol 2003, 5:545-551. 10.1038/ncb994, 12766774.
10. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004, 432:316-323. 10.1038/nature03097, 15549093.
11. Prigent C, Dimitrov S. Phosphorylation of serine 10 in histone H3, what for?. J Cell Sci 2003, 116:3677-3685. 10.1242/jcs.00735, 12917355.
12. Xu B, Kastan MB. Analyzing cell cycle checkpoints after ionizing radiation. Methods Mol Biol 2004, 281:283-292.
13. Hendzel MJ, Wei Y, Mancini MA, Van Hooser A, Ranalli T, Brinkley BR, Bazett-Jones DP, Allis CD. Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 1997, 106:348-360. 10.1007/s004120050256, 9362543.
14. Sauve DM, Anderson HJ, Ray JM, James WM, Roberge M. Phosphorylation-induced rearrangement of the histone H3 NH2-terminal domain during mitotic chromosome condensation. J Cell Biol 1999, 145:225-235. 10.1083/jcb.145.2.225, 2133119, 10209020.
15. Xu B, Kim ST, Lim DS, Kastan MB. Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol Cell Biol 2002, 22:1049-1059. 10.1128/MCB.22.4.1049-1059.2002, 134638, 11809797.
16. Yan Y, Black CP, Cowan KH. Irradiation-induced G2/M checkpoint response requires ERK1/2 activation. Oncogene 2007, 26:4689-4698. 10.1038/sj.onc.1210268, 17297454.
17. Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S. MAPK pathways in radiation responses. Oncogene 2003, 22:5885-5896. 10.1038/sj.onc.1206701, 12947395.
18. Cui W, Yazlovitskaya EM, Mayo MS, Pelling JC, Persons DL. Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal-regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines. Mol Carcinog 2000, 29:219-228. 10.1002/1098-2744(200012)29:4<219::AID-MC1004>3.0.CO;2-D, 11170260.
19. Wang X, McGowan CH, Zhao M, He L, Downey JS, Fearns C, Wang Y, Huang S, Han J. Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol Cell Biol 2000, 20:4543-4552. 10.1128/MCB.20.13.4543-4552.2000, 85840, 10848581.
20. Abbott DW, Holt JT. Mitogen-activated protein kinase kinase 2 activation is essential for progression through the G2/M checkpoint arrest in cells exposed to ionizing radiation. J Biol Chem 1999, 274:2732-2742. 10.1074/jbc.274.5.2732, 9915804.
21. Tang D, Wu D, Hirao A, Lahti JM, Liu L, Mazza B, Kidd VJ, Mak TW, Ingram AJ. ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J Biol Chem 2002, 277:12710-12717. 10.1074/jbc.M111598200, 11821415.
22. Bosco EE, Mulloy JC, Zheng Y. Rac1 GTPase: a "Rac" of all trades. Cell Mol Life Sci 2009, 66:370-374. 10.1007/s00018-008-8552-x, 19151919.
23. Schnelzer A, Prechtel D, Knaus U, Dehne K, Gerhard M, Graeff H, Harbeck N, Schmitt M, Lengyel E. Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 2000, 19:3013-3020. 10.1038/sj.onc.1203621, 10871853.
24. Fritz G, Just I, Kaina B. Rho GTPases are over-expressed in human tumors. Int J Cancer 1999, 81:682-687. 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B, 10328216.
25. Jordan P, Brazao R, Boavida MG, Gespach C, Chastre E. Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors. Oncogene 1999, 18:6835-6839. 10.1038/sj.onc.1203233, 10597294.
26. Singh A, Karnoub AE, Palmby TR, Lengyel E, Sondek J, Der CJ. Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation. Oncogene 2004, 23:9369-9380. 10.1038/sj.onc.1208182, 15516977.
27. Brown JH, Del Re DP, Sussman MA. The Rac and Rho Hall of Fame: a decade of hypertrophic signaling hits. Circ Res 2006, 98:730-742. 10.1161/01.RES.0000216039.75913.9e, 16574914.
28. Eblen ST, Slack JK, Weber MJ, Catling AD. Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes. Mol Cell Biol 2002, 22:6023-6033. 10.1128/MCB.22.17.6023-6033.2002, 134005, 12167697.
29. King AJ, Sun H, Diaz B, Barnard D, Miao W, Bagrodia S, Marshall MS. The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338. Nature 1998, 396:180-183. 10.1038/24184, 9823899.
30. Slack-Davis JK, Eblen ST, Zecevic M, Boerner SA, Tarcsafalvi A, Diaz HB, Marshall MS, Weber MJ, Parsons JT, Catling AD. PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation. J Cell Biol 2003, 162:281-291. 10.1083/jcb.200212141, 2172784, 12876277.
31. Nishida M, Tanabe S, Maruyama Y, Mangmool S, Urayama K, Nagamatsu Y, Takagahara S, Turner JH, Kozasa T, Kobayashi H, Sato Y, Kawanishi T, Inoue R, Nagao T, Kurose H. G alpha 12/13- and reactive oxygen species-dependent activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase by angiotensin receptor stimulation in rat neonatal cardiomyocytes. J Biol Chem 2005, 280:18434-18441.
32. Moore KA, Sethi R, Doanes AM, Johnson TM, Pracyk JB, Kirby M, Irani K, Goldschmidt-Clermont PJ, Finkel T. Rac1 is required for cell proliferation and G2/M progression. Biochem J 1997, 326:17-20. 1218631, 9337845.
33. Michaelson D, Abidi W, Guardavaccaro D, Zhou M, Ahearn I, Pagano M, Philips MR. Rac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division. J Cell Biol 2008, 181:485-496. 10.1083/jcb.200801047, 2364699, 18443222.
34. Soule HD, Maloney TM, Wolman SR, Peterson WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990, 50:6075-6086.
35. Zhao X, Malhotra GK, Lele SM, Lele MS, West WW, Eudy JD, Band H, Band V. Telomerase-immortalized human mammary stem/progenitor cells with ability to self-renew and differentiate. Proc Natl Acad Sci USA 2010, 107:14146-14151. 10.1073/pnas.1009030107, 2922525, 20660721.
36. Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci USA 2004, 101:7618-7623. 10.1073/pnas.0307512101, 419655, 15128949.
37. Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM, Abraham RT. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 1999, 59:4375-4382.
38. Hall-Jackson CA, Cross DA, Morrice N, Smythe C. ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK. Oncogene 1999, 18:6707-6713. 10.1038/sj.onc.1203077, 10597277.
39. Wei Q, Adelstein RS. Pitx2a expression alters actin-myosin cytoskeleton and migration of HeLa cells through Rho GTPase signaling. Mol Biol Cell 2002, 13:683-697. 10.1091/mbc.01-07-0358, 65659, 11854422.
40. Cook JA, Albacker L, August A, Henderson AJ. CD28-dependent HIV-1 transcription is associated with Vav, Rac, and NF-kappa B activation. J Biol Chem 2003, 278:35812-35818. 10.1074/jbc.M302878200, 12842899.
41. Deng K, Gao Y, Cao Z, Graziani EI, Wood A, Doherty P, Walsh FS. Overcoming amino-nogo-induced inhibition of cell spreading and neurite outgrowth by 12-O-tetradecanoylphorbol-13-acetate-type tumor promoters. J Biol Chem 2010, 285:6425-6433. 10.1074/jbc.M109.071548, 2825438, 20018888.
42. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992, 70:401-410. 10.1016/0092-8674(92)90164-8, 1643658.
43. Yan Y, Haas JP, Kim M, Sgagias MK, Cowan KH. BRCA1-induced apoptosis involves inactivation of ERK1/2 activities. J Biol Chem 2002, 277:33422-33430. 10.1074/jbc.M201147200, 12082091.
44. Wang X, Gorospe M, Huang Y, Holbrook NJ. p27Kip1 overexpression causes apoptotic death of mammalian cells. Oncogene 1997, 15:2991-2997. 10.1038/sj.onc.1201450, 9416843.
45. Twigger K, Vidal L, White CL, De Bono JS, Bhide S, Coffey M, Thompson B, Vile RG, Heinemann L, Pandha HS, Errington F, Melcher AA, Harrington KJ. Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy. Clin Cancer Res 2008, 14:912-923. 10.1158/1078-0432.CCR-07-1400, 18245555.
46. Kuo P-L, Hsu Y-L, Cho C-Y. Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells. Mol Cancer Ther 2006, 5:3209-3221. 10.1158/1535-7163.MCT-06-0478, 17172425.
47. Cai Z, Chattopadhyay N, Liu WJ, Chan C, Pignol J-P, Reilly RM. Optimized digital counting colonies of clonogenic assays using ImageJ software and customized macros: comparison with manual counting. Int J Radiat Biol 2011, 87:1135-1146. 10.3109/09553002.2011.622033, 21913819.
48. Xu B, Kim S, Kastan MB. Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol Cell Biol 2001, 21:3445-3450. 10.1128/MCB.21.10.3445-3450.2001, 100266, 11313470.
49. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994, 371:346-347. 10.1038/371346a0, 8090205.
50. Wang Y, Ji P, Liu J, Broaddus RR, Xue F, Zhang W. Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy. Mol Cancer 2009, 8:8. 10.1186/1476-4598-8-8, 2657106, 19216791.
51. Kuntz K, O'Connell MJ. The G(2) DNA damage checkpoint: could this ancient regulator be the Achilles heel of cancer?. Cancer Biol Ther 2009, 8:1433-1439.
52. Wang WH, Hullinger RL, Andrisani OM. Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis. J Biol Chem 2008, 283:25455-25467. 10.1074/jbc.M801934200, 2533071, 18606816.
53. Zhou J, Lim CU, Li JJ, Cai L, Zhang Y. The role of NBS1 in the modulation of PIKK family proteins ATM and ATR in the cellular response to DNA damage. Cancer Lett 2006, 243:9-15. 10.1016/j.canlet.2006.01.026, 16530324.
54. Yoshida T, Zhang Y, Rivera Rosado LA, Chen J, Khan T, Moon SY, Zhang B. Blockade of Rac1 activity induces G1 cell cycle arrest or apoptosis in breast cancer cells through downregulation of cyclin D1, survivin, and X-linked inhibitor of apoptosis protein. Mol Cancer Ther 2010, 9:1657-1668. 10.1158/1535-7163.MCT-09-0906, 20515940.
55. Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene 2001, 20:1803-1815. 10.1038/sj.onc.1204252, 11313928.
56. Lacroix M, Toillon R-A, Leclercq G. p53 and breast cancer, an update. Endocr Relat Cancer 2006, 13:293-325. 10.1677/erc.1.01172, 16728565.
57. Watson NC, Di YM, Orr MS, Fornari FA, Randolph JK, Magnet KJ, Jain PT, Gewirtz DA. Influence of ionizing radiation on proliferation, c-myc expression and the induction of apoptotic cell death in two breast tumour cell lines differing in p53 status. Int J Radiat Biol 1997, 72:547-559. 10.1080/095530097143059, 9374435.
58. Deckbar D, Jeggo PA, Lobrich M. Understanding the limitations of radiation-induced cell cycle checkpoints. Crit Rev Biochem Mol Biol 2011, 46:271-283. 10.3109/10409238.2011.575764, 3171706, 21524151.
59. Kawabe T. G(2) checkpoint abrogators as anticancer drugs. Mol Cancer Ther 2004, 3:513-519.
60. Gewirtz DA. Growth arrest and cell death in the breast tumor cell in response to ionizing radiation and chemotherapeutic agents which induce DNA damage. Breast Cancer Res Treat 2000, 62:223-235. 10.1023/A:1006414422919, 11072787.